Literature DB >> 4986518

In vitro reactivity of lymphocytes to particulate and soluble antigens.

J B Zabriskie, R E Falk.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4986518     DOI: 10.1038/226943a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Superiority of corpuscular BCG to soluble PPD antigen in the leucocyte migration assay.

Authors:  A J Górski
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

2.  Mechanism of buffy coat migration inhibition test.

Authors:  M D Lockshin; J Waxman; M W Jenkins
Journal:  Experientia       Date:  1973-03-15

3.  Skin test reactivity and in vitro responses to microbes and microbial antigens.

Authors:  L Räsänen
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

4.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

Authors:  T Godal; B Myklestad; D R Samuel; B Myrvang
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

5.  Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.

Authors:  E M van de Plassche-Boers; H A Drexhage; M Kokjé-Kleingeld; H A Leezenberg
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 6.  Primary immunodeficiencies.

Authors: 
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever.

Authors:  S E Read; V A Fischetti; V Utermohlen; R E Falk; J B Zabriskie
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.